NASDAQ · STOCK

Eli Lilly and Company

LLY Pharmaceuticals Unknown Updated July 08, 2026
$1,216.24
52W $623.78 – $1249.45
61/100
$1.16T
45.7
0.50
AI Committee Verdict
Lean Buy
-19.2%
100%
Bull & Bear Case
Bull Case
  • Positive MACD histogram signals bullish momentum.
  • Daily trend: uptrend.
  • Weekly trend: uptrend.
  • Daily and weekly trends are both bullish — multi-timeframe alignment, highest confidence.
  • Higher Highs / Higher Lows structure confirms bullish price action.
Bear Case
Insufficient data for bear case.
AI Investment Committee
Committee Consensus As of July 08, 2026
Overall Committee Score
61/100
The AI Investment Committee is an ensemble of six specialized analytical agents: Value Analyst, Technical Analyst, Growth Analyst, Risk Analyst, Macro Analyst, and News Analyst. Each agent independently evaluates LLY using dedicated data signals, then the committee aggregates their verdicts into a final score and recommendation. This multi-agent approach reduces individual model bias and provides a more balanced investment assessment.
View Full Committee Breakdown in Terminal →
Technical Analysis
RSI (14)
69.6
Neutral
MACD Histogram
4.177
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Bollinger %B
0.87
Inside Bands
Price vs Moving Averages
EMA 9
$1,200.16 Above
EMA 21
$1,161.94 Above
EMA 50
$1,098.83 Above
EMA 200
$992.66 Above
Fundamental Analysis
Valuation
0
Growth
100
Profitability
100
Financial Health
55
Valuation
P/E Ratio 45.7×
P/B Ratio 38.29×
PEG Ratio
Dividend Yield 0.56%
52W High $1249.45
52W Low $623.78
Quality & Growth
ROE 10131.0%
ROA 2273.0%
Gross Margin 8283.0%
Operating Margin 4363.0%
Revenue Growth YoY +4744.0%
Debt / Equity 1.60
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 45.7 (rich relative to a 15-40x range); Price-to-book of 38.3x; Revenue growth (YoY) of 47.4%; EPS growth (YoY) of 128.8%; Return on equity of 101.3%; Return on assets of 22.7%; Net margin of 35.0%; Gross margin of 82.8%; Current ratio of 1.58 (healthy short-term liquidity); Debt-to-equity of 1.60; Earnings-history trend unavailable; growth based on TTM year-over-year only.
Key Risks
Risk data not available for LLY.
Get the Full LLY Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal → Mobile